Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126220621 | 12622062 | 1 | I | 20151223 | 20160804 | 20160804 | PER | US-DRREDDYS-USA/USA/15/0055047 | DR REDDYS | SWAIN S, SAMANT S. FIXED DRUG ERUPTION AND FLUCONAZOLE IN A YOUNG WOMAN. ANN ALLERGY ASTHMA IMMUNOL. 2015;115 (5):A64-5. | 35.00 | YR | F | Y | 0.00000 | 20160804 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126220621 | 12622062 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | U | U | UNKNOWN | 75593 | ||||||||
126220621 | 12622062 | 2 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Unknown | U | U | UNKNOWN | 76658 | ||||||||
126220621 | 12622062 | 3 | SS | NAPROXEN SODIUM 220 MG | NAPROXEN SODIUM | 1 | Unknown | U | U | UNKNOWN | 75168 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126220621 | 12622062 | 1 | Urinary tract infection |
126220621 | 12622062 | 2 | Vulvovaginal candidiasis |
126220621 | 12622062 | 3 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126220621 | 12622062 | Drug eruption |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |